Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Overexpression of Akt converts radial growth melanoma to vertical growth melanoma
Baskaran Govindarajan, … , José M. Cuezva, Jack L. Arbiser
Baskaran Govindarajan, … , José M. Cuezva, Jack L. Arbiser
Published March 1, 2007
Citation Information: J Clin Invest. 2007;117(3):719-729. https://doi.org/10.1172/JCI30102.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 3

Overexpression of Akt converts radial growth melanoma to vertical growth melanoma

  • Text
  • PDF
Abstract

Melanoma is the cancer with the highest increase in incidence, and transformation of radial growth to vertical growth (i.e., noninvasive to invasive) melanoma is required for invasive disease and metastasis. We have previously shown that p42/p44 MAP kinase is activated in radial growth melanoma, suggesting that further signaling events are required for vertical growth melanoma. The molecular events that accompany this transformation are not well understood. Akt, a signaling molecule downstream of PI3K, was introduced into the radial growth WM35 melanoma in order to test whether Akt overexpression is sufficient to accomplish this transformation. Overexpression of Akt led to upregulation of VEGF, increased production of superoxide ROS, and the switch to a more pronounced glycolytic metabolism. Subcutaneous implantation of WM35 cells overexpressing Akt led to rapidly growing tumors in vivo, while vector control cells did not form tumors. We demonstrated that Akt was associated with malignant transformation of melanoma through at least 2 mechanisms. First, Akt may stabilize cells with extensive mitochondrial DNA mutation, which can generate ROS. Second, Akt can induce expression of the ROS-generating enzyme NOX4. Akt thus serves as a molecular switch that increases angiogenesis and the generation of superoxide, fostering more aggressive tumor behavior. Targeting Akt and ROS may be of therapeutic importance in treatment of advanced melanoma.

Authors

Baskaran Govindarajan, James E. Sligh, Bethaney J. Vincent, Meiling Li, Jeffrey A. Canter, Brian J. Nickoloff, Richard J. Rodenburg, Jan A. Smeitink, Larry Oberley, Yuping Zhang, Joyce Slingerland, Rebecca S. Arnold, J. David Lambeth, Cynthia Cohen, Lu Hilenski, Kathy Griendling, Marta Martínez-Diez, José M. Cuezva, Jack L. Arbiser

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 4 1 5 10 8 3 6 9 4 6 12 4 10 11 12 14 6 3 128
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (128)

Title and authors Publication Year
LPCAT1 promotes melanoma cell proliferation via Akt signaling
Wang Y, Huang Y, Wang Y, Zhang W, Wang N, Bai R, Luo R, Tuo H, Zheng Y
Oncology reports 2024
Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors
Love NR, Williams C, Killingbeck EE, Merleev A, Saffari Doost M, Yu L, McPherson JD, Mori H, Borowsky AD, Maverakis E, Kiuru M
Science Advances 2024
Oxidative State in Cutaneous Melanoma Progression: A Question of Balance
Benedusi M, Lee H, Lim Y, Valacchi G
Antioxidants 2024
Current Insights into the Role of UV Radiation-Induced Oxidative Stress in Melanoma Pathogenesis
Gieniusz E, Skrzydlewska E, Łuczaj W
International Journal of Molecular Sciences 2024
The role of mitochondria in the resistance of melanoma to PD-1 inhibitors.
Du F, Yang LH, Liu J, Wang J, Fan L, Duangmano S, Liu H, Liu M, Wang J, Zhong X, Zhang Z, Wang F
Journal of Translational Medicine 2023
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches.
Emanuelli M, Sartini D, Molinelli E, Campagna R, Pozzi V, Salvolini E, Simonetti O, Campanati A, Offidani A
2022
Indolium 1 Exerts Activity against Vemurafenib-Resistant Melanoma In Vivo
Radi R, Huang C, Elsey J, Jung YH, Corces VG, Arbiser JL
Antioxidants 2022
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
Adriana Sanna, Bengt Phung, Shamik Mitra, Martin Lauss, Jiyeon Choi, Tongwu Zhang, Ching-Ni Jenny Njauw, Eugenia Cordero, Katja Harbst, Frida Rosengren, Rita Cabrita, Iva Johansson, Karolin Isaksson, Christian Ingvar, Ana Carneiro, Kevin Brown, Hensin Tsao, My Andersson, Kristian Pietras, Göran Jönsson
JCI Insight 2022
Cytoglobin inhibits non-thermal plasma-induced apoptosis in melanoma cells through regulation of the NRF2-mediated antioxidant response
De Backer J, Lin A, Berghe WV, Bogaerts A, Hoogewijs D
Redox Biology 2022
Role of ROS-mediated autophagy in melanoma
Zhang X, Li H, Liu C, Yuan X
Molecular medicine reports 2022
Mitochondrial Metabolism in Melanoma
C Huang, RH Radi, JL Arbiser
Cells 2021
Signal pathways of melanoma and targeted therapy
W Guo, H Wang, C Li
Signal Transduction and Targeted Therapy 2021
NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology
A Vermot, I Petit-Härtlein, SM Smith, F Fieschi
Antioxidants 2021
Cross-Talk between Oxidative Stress and m6A RNA Methylation in Cancer
B Yang, Q Chen, X Zhan
Oxidative Medicine & Cellular Longevity 2021
Oxidative Stress in Cancer Cell Metabolism
S Arfin, NK Jha, SK Jha, KK Kesari, J Ruokolainen, S Roychoudhury, B Rathi, D Kumar
Antioxidants 2021
Genetic deletion of Nox4 enhances cancerogen-induced formation of solid tumors
V Helfinger, FF von Gall, N Henke, MM Kunze, T Schmid, F Rezende, J Heidler, I Wittig, HH Radeke, V Marschall, K Anderson, AM Shah, S Fulda, B Brüne, RP Brandes, K Schröder
Proceedings of the National Academy of Sciences 2021
ROS as Regulators of Cellular Processes in Melanoma
I Venza, M Venza, M Visalli, G Lentini, D Teti, FS d'Alcontres, J Egea
Oxidative Medicine & Cellular Longevity 2021
RGD-targeted redox responsive nano micelle: co-loading docetaxel and indocyanine green to treat the tumor
L Ren, J Nie, J Wei, Y Li, J Yin, X Yang, G Chen
Drug Delivery 2021
ROS Pleiotropy in Melanoma and Local Therapy with Physical Modalities
SK Sagwal, S Bekeschus, B Duan
Oxidative Medicine & Cellular Longevity 2021
Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies
S Pizzimenti, S Ribero, M Cucci, M Grattarola, C Monge, C Dianzani, G Barrera, G Muzio
Antioxidants 2021
NOX2-Derived Reactive Oxygen Species in Cancer
HG Wiktorin, E Aydin, K Hellstrand, A Martner, J Ghose
Oxidative Medicine & Cellular Longevity 2020
Role of Melanin Chemiexcitation in Melanoma Progression and Drug Resistance
S Premi
Frontiers in Oncology 2020
Tumor growth rate as a prognostic factor of acral melanoma in a Korean population
G Jo, SI Cho, Y Cho, J Ohn, JH Mun
Medicine 2020
Akt3 induces oxidative stress and DNA damage by activating the NADPH oxidase via phosphorylation of p47 phox
C Polytarchou, M Hatziapostolou, TO Yau, N Christodoulou, PW Hinds, F Kottakis, I Sanidas, PN Tsichlis
Proceedings of the National Academy of Sciences 2020
Highly efficient singlet oxygen generation, two-photon photodynamic therapy and melanoma ablation by rationally designed mitochondria-specific near-infrared AIEgens
Z Zheng, H Liu, S Zhai, H Zhang, G Shan, RT Kwok, C Ma, HH Sung, ID Williams, JW Lam, KS Wong, X Hu, BZ Tang
Chemical Science 2020
Uncovering the Underlying Mechanisms of Cancer Metabolism through the Landscapes and Probability Flux Quantifications
W Li, J Wang
iScience 2020
A20 promotes melanoma progression via the activation of Akt pathway
J Ma, H Wang, S Guo, X Yi, T Zhao, Y Liu, Q Shi, T Gao, C Li, W Guo
Cell Death and Disease 2020
The multifaceted role of reactive oxygen species in tumorigenesis.
Kirtonia A, Sethi G, Garg M
Cellular and molecular life sciences : CMLS 2020
AKT1 E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis
DA Kircher, KA Trombetti, MR Silvis, GL Parkman, GM Fischer, SN Angel, CM Stehn, SC Strain, AH Grossmann, KL Duffy, KM Boucher, M McMahon, MA Davies, MC Mendoza, MW VanBrocklin, SL Holmen
Molecular cancer research : MCR 2019
Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy
Chamcheu, Roy, Uddin, BM, Chamcheu, Walker, Liu, Huang
Cells 2019
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
V Aggarwal, H Tuli, A Varol, F Thakral, M Yerer, K Sak, M Varol, A Jain, Khan, G Sethi
Biomolecules 2019
Regulation of Tumor Progression by Programmed Necrosis
SY Lee, MK Ju, HM Jeon, EK Jeong, YJ Lee, CH Kim, HG Park, SI Han, HS Kang
Oxidative medicine and cellular longevity 2018
Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype
SY Lee, MK Ju, HM Jeon, YJ Lee, CH Kim, HG Park, SI Han, HS Kang
Oxidative medicine and cellular longevity 2018
The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance
MS Weng, JH Chang, WY Hung, YC Yang, MH Chien
Journal of Experimental & Clinical Cancer Research 2018
AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity
S Brolih, SK Parks, V Vial, J Durivault, L Mostosi, J Pouysségur, G Pagès, V Picco
BMC Cancer 2018
NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease
E Aydin, A Hallner, HG Wiktorin, A Staffas, K Hellstrand, A Martner
Oncogene 2018
Akt‐mediated phosphorylation of MICU1 regulates mitochondrial Ca 2+ levels and tumor growth
S Marchi, M Corricelli, A Branchini, VA Vitto, S Missiroli, G Morciano, M Perrone, M Ferrarese, C Giorgi, M Pinotti, L Galluzzi, G Kroemer, P Pinton
The EMBO Journal 2018
NADPH Oxidase Deficiency: A Multisystem Approach
G Giardino, MP Cicalese, O Delmonte, M Migliavacca, B Palterer, L Loffredo, E Cirillo, V Gallo, F Violi, C Pignata
Oxidative medicine and cellular longevity 2017
Antitumor agent 25-epi Ritterostatin GN1N induces endoplasmic reticulum stress and autophagy mediated cell death in melanoma cells
KB Ahmed, AK Kanduluru, L Feng, PL Fuchs, P Huang
International journal of oncology 2017
Cooperation between p21 and Akt is required for p53-dependent cellular senescence
YY Kim, HJ Jee, JH Um, YM Kim, SS Bae, J Yun
Aging Cell 2017
Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation
SY Lee, EK Jeong, MK Ju, HM Jeon, MY Kim, CH Kim, HG Park, SI Han, HS Kang
Molecular Cancer 2017
Influence of node abundance on signaling network state and dynamics analyzed by mass cytometry
XK Lun, VR Zanotelli, JD Wade, D Schapiro, M Tognetti, N Dobberstein, B Bodenmiller
Nature Biotechnology 2017
NADPH Oxidases: Insights into Selected Functions and Mechanisms of Action in Cancer and Stem Cells
M Skonieczna, T Hejmo, A Poterala-Hejmo, A Cieslar-Pobuda, RJ Buldak
Oxidative medicine and cellular longevity 2017
Targeting the duality of cancer
JL Arbiser, MY Bonner, LC Gilbert
npj Precision Oncology 2017
Toxicity and Immunogenicity in Murine Melanoma following Exposure to Physical Plasma-Derived Oxidants
S Bekeschus, K Rödder, B Fregin, O Otto, M Lippert, KD Weltmann, K Wende, A Schmidt, RK Gandhirajan
Oxidative medicine and cellular longevity 2017
Transcriptome Analysis of Canine Cutaneous Melanoma and Melanocytoma Reveals a Modulation of Genes Regulating Extracellular Matrix Metabolism and Cell Cycle
C Brachelente, K Cappelli, S Capomaccio, I Porcellato, S Silvestri, L Bongiovanni, RD Maria, AV Supplizi, L Mechelli, M Sforna
Scientific Reports 2017
Macrophage Akt1 Kinase-Mediated Mitophagy Modulates Apoptosis Resistance and Pulmonary Fibrosis
JL Larson-Casey, JS Deshane, AJ Ryan, VJ Thannickal, AB Carter
Immunity 2016
Melanoma Brain Metastasis: Mechanisms, Models, and Medicine
D Kircher, M Silvis, J Cho, S Holmen
International journal of molecular sciences 2016
Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway
C Zhou, X Chen, W Zeng, C Peng, G Huang, X Li, Z Ouyang, Y Luo, X Xu, B Xu, W Wang, R He, X Zhang, L Zhang, J Liu, TC Knepper, Y He, HL McLeod
Oncotarget 2016
Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo.
Bonner MY, Karlsson I, Rodolfo M, Arnold RS, Vergani E, Arbiser JL
Oncotarget 2016
Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism
PE Porporato, VL Payen, B Baselet, P Sonveaux
Cellular and Molecular Life Sciences 2015
Cellular Mechanisms of Oxidative Stress and Action in Melanoma
M Venza, M Visalli, C Beninati, GV de Gaetano, D Teti, I Venza
Oxidative medicine and cellular longevity 2015
NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation
T Namiki, T Yaguchi, K Nakamura, JC Valencia, SG Coelho, L Yin, M Kawaguchi, WD Vieira, Y Kaneko, A Tanemura, I Katayama, H Yokozeki, Y Kawakami, VJ Hearing
Cancer research 2015
Mechanisms of Superoxide Signaling in Epigenetic Processes: Relation to Aging and Cancer
I Afanas’ev
Aging and disease 2015
NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells
AK Jayavelu, JP Müller, R Bauer, SA Böhmer, J Lässig, S Cerny-Reiterer, WR Sperr, P Valent, B Maurer, R Moriggl, K Schröder, AM Shah, M Fischer, S Scholl, J Barth, T Oellerich, T Berg, H Serve, S Frey, T Fischer, FH Heidel, FD Böhmer
Leukemia 2015
The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis.
Peres J, Mowla S, Prince S
Oncotarget 2015
NADPH Oxidases in Vascular Pathology
A Konior, A Schramm, M Czesnikiewicz-Guzik, TJ Guzik
Antioxidants & Redox Signaling 2014
Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: Findings from 3-D melanoma skin equivalents and computational modeling
DN Syed, JC Chamcheu, MI Khan, M Sechi, RK Lall, VM Adhami, H Mukhtar
Biochemical Pharmacology 2014
Melanocytes as Instigators and Victims of Oxidative Stress
L Denat, AL Kadekaro, L Marrot, SA Leachman, ZA Abdel-Malek
Journal of Investigative Dermatology 2014
PHIPing Out: A Genetic Basis for Tumor Ulceration
JL Arbiser
Journal of Investigative Dermatology 2014
Updates of reactive oxygen species in melanoma etiology and progression
F Liu-Smith, R Dellinger, FL Meyskens
Archives of Biochemistry and Biophysics 2014
Current approaches to the treatment of metastatic brain tumours
TK Owonikoko, J Arbiser, A Zelnak, HK Shu, H Shim, AM Robin, SN Kalkanis, TG Whitsett, B Salhia, NL Tran, T Ryken, MK Moore, KM Egan, JJ Olson
Nature Reviews Clinical Oncology 2014
Butein suppresses breast cancer growth by reducing a production of intracellular reactive oxygen species
SG Cho, SM Woo, SG Ko
Journal of Experimental & Clinical Cancer Research 2014
Amyloids, melanins and oxidative stress in melanomagenesis
F Liu-Smith, C Poe, PJ Farmer, FL Meyskens
Experimental Dermatology 2014
The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer
MY Bonner, JL Arbiser
Future Medicinal Chemistry 2014
In vitro evaluation of novel N-acetylalaninate prodrugs that selectively induce apoptosis in prostate cancer cells
CA McGoldrick, YL Jiang, M Brannon, K Krishnan, WL Stone
BMC Cancer 2014
A Signal Transduction Pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its Correlation with Progression in Human Melanoma
X Qu, L Shen, Y Zheng, Y Cui, Z Feng, F Liu, J Liu
Journal of Investigative Dermatology 2014
Regulation of NADPH-dependent Nitric Oxide and reactive oxygen species signalling in endothelial and melanoma cells by a photoactive NADPH analogue
Rouaud F, Romero-Perez M, Wang H, Lobysheva I, Ramassamy B, Henry E, Tauc P, Giacchero D, Boucher JL, Deprez E, Rocchi S, Slama-Schwok A
Oncotarget 2014
Effects of Iodonium-Class Flavin Dehydrogenase Inhibitors on Growth, Reactive Oxygen Production, Cell Cycle Progression, NADPH Oxidase 1 Levels, and Gene Expression in Human Colon Cancer Cells and Xenografts
JH Doroshow, S Gaur, S Markel, J Lu, J Balgooy, TW Synold, B Xi, X Wu, A Juhasz
Free radical biology & medicine 2013
Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody
S Antony, Y Wu, SM Hewitt, MR Anver, D Butcher, G Jiang, JL Meitzler, H Liu, A Juhasz, J Lu, KK Roy, JH Doroshow
Free radical biology & medicine 2013
RedOx status, proteasome and APEH: insights into anticancer mechanisms of t10,c12-conjugated linoleic acid isomer on A375 melanoma cells
P Bergamo, E Cocca, R Palumbo, M Gogliettino, M Rossi, G Palmieri
PloS one 2013
Nox-derived ROS are acutely activated in pressure overload pulmonary hypertension: indications for a seminal role for mitochondrial Nox4
G Frazziano, IA Ghouleh, J Baust, S Shiva, HC Champion, PJ Pagano
American journal of physiology. Heart and circulatory physiology 2013
Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis
DD Semir, M Nosrati, V Bezrookove, AA Dar, S Federman, G Bienvenu, S Venna, J Rangel, J Climent, TM Tamgüney, S Thummala, S Tong, SP Leong, C Haqq, P Billings, JR 3rd, RW Sagebiel, R Debs, M Kashani-Sabet
Proceedings of the National Academy of Sciences 2012
High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis
D Mougiakakos, R Okita, T Ando, C Dürr, J Gadiot, J Ichikawa, R Zeiser, C Blank, CC Johansson, R Kiessling
Journal of Molecular Medicine 2012
Thiostrepton is an Inducer of Oxidative and Proteotoxic Stress that Impairs Viability of Human Melanoma Cells but not Primary Melanocytes
S Qiao, SD Lamore, CM Cabello, JL Lesson, JL Muñoz-Rodriguez, GT Wondrak
Biochemical Pharmacology 2012
Targeting NADPH oxidases for the treatment of cancer and inflammation
MY Bonner, JL Arbiser
Cellular and Molecular Life Sciences 2012
Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress
SK Natarajan, DF Becker
Cell health and cytoskeleton 2012
Jacaranone Induces Apoptosis in Melanoma Cells via ROS-Mediated Downregulation of Akt and p38 MAPK Activation and Displays Antitumor Activity In Vivo
MH Massaoka, AL Matsuo, CR Figueiredo, CF Farias, N Girola, DC Arruda, JA Scutti, P Romoff, OA Favero, MJ Ferreira, JH Lago, LR Travassos
PloS one 2012
Aiding and abetting roles of NOX oxidases in cellular transformation
K Block, Y Gorin
Nature Reviews Cancer 2012
A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma
E Bonvin, P Falletta, H Shaw, V Delmas, CR Goding
Molecular and cellular biology 2012
1,3-Bis(3,5-dichlorophenyl) urea compound 'COH-SR4' inhibits proliferation and activates apoptosis in melanoma
SS Singhal, J Figarola, J Singhal, K Leake, L Nagaprashantha, C Lincoln, BG Gugiu, D Horne, R Jove, S Awasthi, S Rahbar
Biochemical Pharmacology 2012
Glutamine-fueled mitochondrial metabolism is decoupled from glycolysis in melanoma
FV Filipp, B Ratnikov, JD Ingeniis, JW Smith, AL Osterman, DA Scott
Pigment Cell & Melanoma Research 2012
Redox signaling in cardiac myocytes
CX Santos, N Anilkumar, M Zhang, AC Brewer, AM Shah
Free radical biology & medicine 2011
Therapeutic Implications of Targeting AKT Signaling in Melanoma
SV Madhunapantula, GP Robertson
Enzyme Research 2011
Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth
Q Sun, X Chen, J Ma, H Peng, F Wang, X Zha, Y Wang, Y Jing, H Yang, R Chen, L Chang, Y Zhang, J Goto, H Onda, T Chen, MR Wang, Y Lu, H You, D Kwiatkowski, H Zhang
Proceedings of the National Academy of Sciences 2011
Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival
G Chen, Y Cheng, Z Zhang, M Martinka, G Li
PloS one 2011
The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis
CM Cabello, SD Lamore, WB Bair, S Qiao, S Azimian, JL Lesson, GT Wondrak
Investigational New Drugs 2011
NADPH Oxidase Activation Is Required in Reactive Oxygen Species Generation and Cell Transformation Induced by Hexavalent Chromium
X Wang, YO Son, Q Chang, L Sun, JA Hitron, A Budhraja, Z Zhang, Z Ke, F Chen, J Luo, X Shi
Toxicological Sciences 2011
Effective inhibition of melanoma by BI-69A11 is mediated by dual targeting of the AKT and NF-κB pathways
Y Feng, E Barile, SK De, JL Stebbins, A Cortez, P Aza-Blanc, J Villanueva, M Heryln, S Krajewski, M Pellecchia, ZA Ronai, GG Chiang
Pigment Cell & Melanoma Research 2011
Resveratrol Modulates the Malignant Properties of Cutaneous Melanoma via Changes in the Activation and Attenuation of the Anti-apoptotic Proto-oncogenic Protein Akt/PKB
S Bhattacharya, SR Darjatmoko, AS Polans
Melanoma Research 2011
Inhibition of human melanoma cell growth by dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels
DN Syed, F Afaq, N Maddodi, JJ Johnson, S Sarfaraz, A Ahmad, V Setaluri, H Mukhtar
Journal of Investigative Dermatology 2011
An extracellular signal-regulated kinase 2 survival pathway mediates resistance of human mesothelioma cells to asbestos-induced injury
A Shukla, TF Barrett, MB MacPherson, JM Hillegass, NK Fukagawa, WA Swain, KJ O'Byrne, JR Testa, HI Pass, SP Faux, BT Mossman
American journal of respiratory cell and molecular biology 2011
Roles of AKT1 and AKT2 in non‐small cell lung cancer cell survival, growth, and migration
Lee MW, Kim DS, Lee JH, Lee BS, Lee SH, Jung HL, Sung KW, Kim HT, Yoo KH, Koo HH
Cancer Science 2011
Survivin enhances motility of melanoma cells by supporting Akt activation and α5 integrin upregulation
JA McKenzie, T Liu, AG Goodson, D Grossman
Cancer research 2010
GLO1 overexpression in human malignant melanoma
WB 3rd, CM Cabello, K Uchida, AS Bause, GT Wondrak
Melanoma Research 2010
Effects of HIF-1alpha and HIF2alpha on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts
S Biswas, H Troy, R Leek, YL Chung, JL Li, RR Raval, H Turley, K Gatter, F Pezzella, JR Griffiths, M Stubbs, AL Harris
Journal of Oncology 2010
Inhibitory effects of Lang-du extract on the in vitro and in vivo growth of melanoma cells and its molecular mechanisms of action
L Wang, H Duan, Y Wang, K Liu, P Jiang, Z Qu, K Yagasaki, G Zhang
Cytotechnology 2010
AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1)
SS Shin, BA Wall, JS Goydos, S Chen
Pigment Cell & Melanoma Research 2010
Fyn is Induced by Ras/PI3K/Akt Signaling and is Required for Enhanced Invasion/Migration
V Yadav, MF Denning
Molecular Carcinogenesis 2010
NADPH Oxidase Activation in Pancreatic Cancer Cells Is Mediated through Akt-dependent Up-regulation of p22phox*
M Edderkaoui, C Nitsche, L Zheng, SJ Pandol, I Gukovsky, AS Gukovskaya
The Journal of biological chemistry 2010
Melanoma Chemoprevention in Skin Reconstructs and Mouse Xenografts Using Isoselenocyanate-4
N Nguyen, A Sharma, N Nguyen, AK Sharma, D Desai, SJ Huh, S Amin, C Meyers, GP Robertson
Cancer prevention research (Philadelphia, Pa.) 2010
Metastasis in an Orthotopic Murine Model of Melanoma is Independent of RAS/RAF Mutation
GI Rozenberg, KB Monahan, C Torrice, JE Bear, NE Sharpless
Melanoma Research 2010
Reactive oxygen species in cancer
GY Liou, P Storz
Free Radical Research 2010
Vertical Targeting of the Phosphatidylinositol-3 Kinase Pathway as a Strategy for Treating Melanoma
SA Aziz, LB Jilaveanu, C Zito, RL Camp, DL Rimm, P Conrad, HM Kluger
Clinical cancer research 2010
Akt3-Mediated Resistance to Apoptosis in B-RAF–Targeted Melanoma Cells
Y Shao, AE Aplin
Cancer research 2010
Requirement of NADPH oxidase 4 (Nox4) for hemangioma growth in vivo, and discovery of fulvenes as small molecular NADPH oxidase inhibitors
Sulochana S. Bhandarkar, Marisa Jaconi, Benjamin Lefkove, Levi Fried, Baskaran Govindarajan, Betsy N. Perry, Allie Sohn, Michael Stouffs, Ulla Knaus, George Yancopoulos, Hellmut Augustin, Jack Arbiser
Journal of Clinical Investigation 2009
Functional RET G691S polymorphism in cutaneous malignant melanoma
N Narita, A Tanemura, R Murali, RA Scolyer, S Huang, T Arigami, S Yanagita, KK Chong, JF Thompson, DL Morton, DS Hoon
Oncogene 2009
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma
SR Madhunapantula, GP Robertson
Pigment Cell & Melanoma Research 2009
Redox-directed cancer therapeutics: molecular mechanisms and opportunities
GT Wondrak
Antioxidants & Redox Signaling 2009
Probing Akt-inhibitor interaction by chemical cross-linking and mass spectrometry
BX Huang, HY Kim
Journal of the American Society for Mass Spectrometry 2009
Molecular markers of tumor progression in melanoma
J Rother, D Jones
Current genomics 2009
Use of oral N-acetylcysteine for protection of melanocytic nevi against UV-induced oxidative stress: towards a novel paradigm for melanoma chemoprevention
AG Goodson, MA Cotter, P Cassidy, M Wade, SR Florell, T Liu, KM Boucher, D Grossman
Clinical cancer research 2009
RGS16 inhibits breast cancer cell growth by mitigating phosphatidylinositol 3-kinase signaling
G Liang, G Bansal, Z Xie, KM Druey
The Journal of biological chemistry 2009
Ras and Nox: Linked signaling networks?
RF Wu, LS Terada
Free radical biology & medicine 2009
BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma
S Gaitonde, SK De, M Tcherpakov, A Dewing, H Yuan, M Riel-Mehan, S Krajewski, G Robertson, M Pellecchia, Z Ronai
Pigment Cell & Melanoma Research 2009
The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth
CM Cabello, WB 3rd, SD Lamore, S Ley, AS Bause, S Azimian, GT Wondrak
Free radical biology & medicine 2009
Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma
SA Aziz, M Davies, E Pick, C Zito, L Jilaveanu, RL Camp, DL Rimm, Y Kluger, HM Kluger
Clinical cancer research 2009
Cancer Abolishes the Tissue Type-Specific Differences in the Phenotype of Energetic Metabolism
Acebo P, Giner D, Calvo P, Blanco-Rivero A, Ortega ÁD, Fernández PL, Roncador G, Fernández-Malavé E, Chamorro M, Cuezva JM
Translational oncology 2009
Notch1 is an effector of Akt and hypoxia in melanoma development
Barbara Bedogni, James A. Warneke, Brian J. Nickoloff, Amato J. Giaccia and Marianne Broome Powell
Journal of Clinical Investigation 2008
NOX enzymes as novel targets for drug development
JD Lambeth, KH Krause, RA Clark
Seminars in Immunopathology 2008
Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy
M Ushio-Fukai, Y Nakamura
Cancer Letters 2008
Application of angiogenesis to clinical dermatology
LE Fried, JL Arbiser
Advances in Dermatology 2008
The JmjC Domain Histone Demethylase Ndy1 Regulates Redox Homeostasis and Protects Cells from Oxidative Stress
C Polytarchou, R Pfau, M Hatziapostolou, PN Tsichlis
Molecular and cellular biology 2008
Malignant Melanoma in the 21st Century: The Emerging Molecular Landscape
Sekulic A, Haluska P Jr, Miller AJ, De Lamo JG, Ejadi S, Pulido JS, Salomao DR, Thorland EC, Vile RG, Swanson DL, Pockaj BA, Laman SD, Pittelkow MR, Markovic SN
Mayo Clinic proceedings. Mayo Clinic 2008
Why targeted therapy hasn’t worked in advanced cancer
Jack L. Arbiser
Journal of Clinical Investigation 2007
Understanding signaling cascades in melanoma
P Lopez-Bergami, B Fitchman, Z Ronai
Photochemistry and Photobiology 2007
Growth factors and oncogenes as targets in melanoma: lost in translation?
L Kwong, L Chin, SN Wagner
Advances in Dermatology 2007

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
134 readers on Mendeley
See more details